Capital Health Care (CHC)

Founded in 2022, CHC (Capital Health Care) was established with a clear and ambitious vision: to position itself as a leading pharmaceutical company in pediatric healthcare through the development and commercialization of a high-quality, premium, and diversified product portfolio.

As an Egyptian pharmaceutical company, CHC is committed to addressing the evolving healthcare needs of Egyptian patients by delivering safe, effective, and reliable therapeutic solutions. The company operates in full alignment with the highest standards of quality, regulatory compliance, and ethical business practices, ensuring that every product meets rigorous scientific and manufacturing benchmarks.

At CHC, our commitment extends beyond business growth. We strive to create sustainable value for our shareholders and partners while upholding our responsibility to patients, healthcare professionals, and the broader community.